Apoptosis: Potential therapeutic targets for new drug discovery

被引:33
作者
Jana, Snehasis [1 ]
Paliwal, Jyoti [1 ]
机构
[1] New Drug Discovery Res, Ranbaxy Res Labs, Metab & Pharmakokinet Div, Gurgaon 122015, Haryana, India
关键词
apoptosis; programmed cell death; caspases; death receptors; Bcl-2; mitochondria; XIAP;
D O I
10.2174/092986707781745569
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apoptosis is involved in a wide range of pathologic conditions, including neurodegenerative, autoimmune diseases, cardiovascular diseases and cancer. Therefore, the ability to understand and manipulate the cell death machinery is an obvious goal of medical research. Novel therapeutic approaches to modulate disease by regulating apoptosis are being tested in preclinical and clinical settings. Approaches include the traditional use of small molecules to target specific players in the apoptosis cascade. As our understanding of apoptosis increases, further opportunities will arise for tailor-made therapies that will result in improved clinic. From variety of compounds are discovered in this field and only few are found in the preclinical and clinical trials. The lack of specific potent nonpeptide apoptosis inducers and/or inhibitors has limited for a long time the clinical investigation of this target. But in the last few years the renewed interest of pharmaceutical companies has been giving a strong impulse to the research in this area. This review considers the molecular mechanisms of apoptosis and their interaction in regulation of apoptosis. We also focus on recent developments of nonpeptide apoptosis modulators and their progress in drug lead discovery.
引用
收藏
页码:2369 / 2379
页数:11
相关论文
共 108 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   Bcl-2 family regulation of neuronal development and neurodegeneration [J].
Akhtar, RS ;
Ness, JM ;
Roth, KA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1644 (2-3) :189-203
[3]   Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization [J].
Arnoult, D ;
Gaume, B ;
Karbowski, M ;
Sharpe, JC ;
Cecconi, F ;
Youle, RJ .
EMBO JOURNAL, 2003, 22 (17) :4385-4399
[4]   Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ [J].
Arnt, CR ;
Chiorean, MV ;
Heldebrant, MV ;
Gores, GJ ;
Kaufmann, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) :44236-44243
[5]   Recruitment, activation and retention of caspases-9 and-3 by Apaf-1 apoptosome and associated XIAP complexes [J].
Bratton, SB ;
Walker, G ;
Srinivasula, SM ;
Sun, XM ;
Butterworth, M ;
Alnemri, ES ;
Cohen, GM .
EMBO JOURNAL, 2001, 20 (05) :998-1009
[6]   Regulation of mitochondrial membrane premeabilization by BCL-2 family proteins and caspases [J].
Breckenridge, DG ;
Xue, D .
CURRENT OPINION IN CELL BIOLOGY, 2004, 16 (06) :647-652
[7]   Apoptosis: Overview and signal transduction pathways [J].
Bredesen, DE .
JOURNAL OF NEUROTRAUMA, 2000, 17 (10) :801-810
[8]   INTRACELLULAR SIGNALING BY 14-HYDROXY-4,14-RETRO-RETINOL [J].
BUCK, J ;
DERGUINI, F ;
LEVI, E ;
NAKANISHI, K ;
HAMMERLING, U .
SCIENCE, 1991, 254 (5038) :1654-1656
[9]   Novel anticancer drug discovery [J].
Buolamwini, JK .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) :500-509
[10]   Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay [J].
Cai, SX ;
Nguyen, B ;
Jia, SJ ;
Herich, J ;
Guastella, J ;
Reddy, S ;
Tseng, B ;
Drewe, J ;
Kasibhatla, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) :2474-2481